197 related articles for article (PubMed ID: 31466367)
1. Proliferation in Postmenopausal Endometrial Polyps-A Potential for Malignant Transformation.
Adomaitienė L; Nadišauskienė R; Nickkho-Amiry M; Čižauskas A; Palubinskienė J; Holland C; Seif MW
Medicina (Kaunas); 2019 Aug; 55(9):. PubMed ID: 31466367
[No Abstract] [Full Text] [Related]
2. Tumor Suppression in Asymptomatic Postmenopausal Endometrial Polyps.
Adomaitiene L; Nadisauskiene R; Nickkho-Amiry M; Cizauskas A; Palubinskiene J; Holland C; Seif MW
Anticancer Res; 2020 Feb; 40(2):789-794. PubMed ID: 32014921
[TBL] [Abstract][Full Text] [Related]
3. Postmenopausal status, hypertension and obesity as risk factors for malignant transformation in endometrial polyps.
Giordano G; Gnetti L; Merisio C; Melpignano M
Maturitas; 2007 Feb; 56(2):190-7. PubMed ID: 16963204
[TBL] [Abstract][Full Text] [Related]
4. Is the immunohistochemical expression of proliferation (Ki-67) and apoptosis (Bcl-2) markers and cyclooxigenase-2 (COX-2) related to carcinogenesis in postmenopausal endometrial polyps?
Antunes A; Andrade LA; Pinto GA; Leão R; Pinto-Neto AM; Costa-Paiva L
Anal Quant Cytopathol Histpathol; 2012 Oct; 34(5):264-72. PubMed ID: 23301386
[TBL] [Abstract][Full Text] [Related]
5. Expression of p53, Ki-67, and CD31 proteins in endometrial polyps of postmenopausal women treated with tamoxifen.
Miranda SP; Traiman P; Cândido EB; Lages EL; Freitas GF; Lamaita RM; Vidigal PV; da Silva Filho AL
Int J Gynecol Cancer; 2010 Dec; 20(9):1525-30. PubMed ID: 21119367
[TBL] [Abstract][Full Text] [Related]
6. Occurrence of malignancy in endometrial polyps during postmenopause.
Mossa B; Torcia F; Avenoso F; Tucci S; Marziani R
Eur J Gynaecol Oncol; 2010; 31(2):165-8. PubMed ID: 20527232
[TBL] [Abstract][Full Text] [Related]
7. Proliferative activity in postmenopausal endometrium: the lurking potential for giving rise to an endometrial adenocarcinoma.
Sivridis E; Giatromanolaki A
J Clin Pathol; 2004 Aug; 57(8):840-4. PubMed ID: 15280405
[TBL] [Abstract][Full Text] [Related]
8. Expression of Bcl-2 and Ki-67 in tamoxifen-associated endometrial polyps: comparison with postmenopausal polyps.
Altaner S; Gucer F; Tokatli F; Guresci S; Ozdemir C; Puyan FO; Kutlu K
Onkologie; 2006 Sep; 29(8-9):376-80. PubMed ID: 16974115
[TBL] [Abstract][Full Text] [Related]
9. Endometrial polyps in pre- and postmenopausal women: factors associated with malignancy.
Antunes A; Costa-Paiva L; Arthuso M; Costa JV; Pinto-Neto AM
Maturitas; 2007 Aug; 57(4):415-21. PubMed ID: 17587515
[TBL] [Abstract][Full Text] [Related]
10. Endometrial microcalcifications detected by ultrasonography: clinical associations, histopathology, and potential etiology.
Truskinovsky AM; Gerscovich EO; Duffield CR; Vogt PJ
Int J Gynecol Pathol; 2008 Jan; 27(1):61-7. PubMed ID: 18156977
[TBL] [Abstract][Full Text] [Related]
11. [Clinical characteristics of 42 cases of malignant endometrial polyps].
Tang Z; Zhou R; Bao D; Liu C; Wei L
Zhonghua Fu Chan Ke Za Zhi; 2014 Mar; 49(3):204-7. PubMed ID: 24820306
[TBL] [Abstract][Full Text] [Related]
12. Hormone receptor expressions and proliferation markers in postmenopausal endometrial polyps.
Inceboz US; Nese N; Uyar Y; Ozcakir HT; Kurtul O; Baytur YB; Kandiloglu AR; Caglar H; Fraser IS
Gynecol Obstet Invest; 2006; 61(1):24-8. PubMed ID: 16141722
[TBL] [Abstract][Full Text] [Related]
13. Expression of p53 in endometrial polyps with special reference to the p53 signature.
Sho T; Hachisuga T; Kawagoe T; Urabe R; Kurita T; Kagami S; Shimajiri S; Fujino Y
Histol Histopathol; 2016 Jul; 31(7):751-8. PubMed ID: 26727623
[TBL] [Abstract][Full Text] [Related]
14. Is there a survival advantage in diagnosing endometrial cancer in asymptomatic postmenopausal patients? An Israeli Gynecology Oncology Group study.
Gemer O; Segev Y; Helpman L; Hag-Yahia N; Eitan R; Raban O; Vaknin Z; Leytes S; Ben Arie A; Amit A; Levy T; Namazov A; Volodarsky M; Ben Shachar I; Atlas I; Bruchim I; Lavie O
Am J Obstet Gynecol; 2018 Aug; 219(2):181.e1-181.e6. PubMed ID: 29792852
[TBL] [Abstract][Full Text] [Related]
15. Association of ovarian hyperthecosis with endometrial polyp, endometrial hyperplasia, and endometrioid adenocarcinoma in postmenopausal women: a clinicopathological study of 238 cases.
Zhang C; Sung CJ; Quddus MR; Simon RA; Jazaerly T; Lawrence WD
Hum Pathol; 2017 Jan; 59():120-124. PubMed ID: 27746268
[TBL] [Abstract][Full Text] [Related]
16. How often are endometrial polyps malignant?
Shushan A; Revel A; Rojansky N
Gynecol Obstet Invest; 2004; 58(4):212-5. PubMed ID: 15316149
[TBL] [Abstract][Full Text] [Related]
17. Expression of COX-2, Ki-67, cyclin D1, and P21 in endometrial endometrioid carcinomas.
Cao QJ; Einstein MH; Anderson PS; Runowicz CD; Balan R; Jones JG
Int J Gynecol Pathol; 2002 Apr; 21(2):147-54. PubMed ID: 11917224
[TBL] [Abstract][Full Text] [Related]
18. The significance of intrauterine lesions detected by ultrasound in asymptomatic postmenopausal patients.
Lev-Sagie A; Hamani Y; Imbar T; Hurwitz A; Lavy Y
BJOG; 2005 Mar; 112(3):379-81. PubMed ID: 15713160
[TBL] [Abstract][Full Text] [Related]
19. Tamoxifen use and endometrial lesions: hysteroscopic, histological, and immunohistochemical findings in postmenopausal women with breast cancer.
Dibi RP; Zettler CG; Pessini SA; Ayub AV; de Almeida SB; da Silveira GP
Menopause; 2009; 16(2):293-300. PubMed ID: 19034048
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical expression of estrogen and progesterone receptors in endometrial polyps and its relationship to clinical parameters.
Gul A; Ugur M; Iskender C; Zulfikaroglu E; Ozaksit G
Arch Gynecol Obstet; 2010 Mar; 281(3):479-83. PubMed ID: 19506890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
